Image of The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and classifiable epilepsy: an unblinded randomised controlled trial

LITERATURE

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and classifiable epilepsy: an unblinded randomised controlled trial


Valproate is widely accepted as a drug of first choice for patients with generalised onset seizures, and its broad spectrum of efficacy means it is recommended for patients with seizures that are difficult to classify. Lamotrigine and topiramate are also thought to possess broad spectrum activity.


Availability

Procifer-003Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Lancet. 2007 March 24; 369(9566): 1016–1026
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous